We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.
By clicking "Allow All" you agree to the storing of cookies on your device to enhance site navigation, analyse site usage and support us in providing free open access scientific content. More info.
During this webinar, Fabrice and Anna will introduce you to Bruker’s newly launched PotencyMR, a solution specially designed to facilitate potency/purity determination. You will also have an update on the existing tools for absolute concentration determination using an external reference.
A full automatic workflow from sample submission to report will be shown which includes the measurement of replicate samples. You will see how challenging samples (formulated material) are also analyzed, in manual mode, and how this manual analysis can be stored for further reuse.
They will describe the NMR hardware that is best suited for Bruker’s qNMR and show how that complements LC methods in a very cost effective way. Example data and practical cases at 300 and 500 MHz will be shown.
All along the webinar key benefits of PotencyMR, such as ease of use and review, that make the solution accessible to non-NMR experts, will be highlighted, demonstrating that the deployment of qNMR to an open access environment is now a reality.
Anna Codina, Ph.D. (Biography), Product Portfolio Manager, Pharma Market - Bruker UK Limited, Coventry, U.K.
Fabrice Moriaud, Ph.D. (Biography), Product Manager PotencyMR - Fällanden, Switzerland
Analytical chemists and laboratory managers, chromatographers, pharmaceutical sciences and pharmaceutical development leaders, laboratory technicians and NMR spectroscopists from pharmaceutical, fine chemistry, petro chemistry, forensics and food industries. The webinar is especially relevant for those working in development and quality control environments.
Dynamic Nuclear Polarization in the study of pharmaceuticals
High speed spectroscopy – New AVANCE NEO
Is it really pure honey? Detecting adulterations, frauds and quality issues by NMR-based Honey-Profiling
Solid State NMR Made Easy
In Vivo Tumor Progression Studies: The Relative Strengths of Available Imaging Modalities and Reporter Constructs
Studying Cancer biology and Therapeutic Targets Using PET Technology: Opening an Extraordinary Option
Automatizing the qualitative and quantitative analysis of complex drugs using NMR
Imaging of Infection and Tumors using labelled Siderophores
Metabolic Imaging in Neurodegenerative Disease using CEST MRI
In vivo Magnetic Resonance Imaging
NMR-based fragment screening for drug discovery
Pharmaceutical Applications of Electron Paramagnetic Resonance (EPR) Spectroscopy
Improving Mechanistic Understanding of Fast Reactions Using Rapid, Reproducible In Situ Analysis by Stop-Flow NMR and IR
A Universal MicroCT Analysis Pipeline for Bone Preclinical Disease Models
EPR as a Teaching Tool in the Laboratory
How microCT Can Provide Insight into Dynamic Disease Processes
Solid Form Quantification – A New Benchtop Solution
Webinar Overview: EPR as a Teaching Tool in the Laboratory
Intelligent Use of NMR for Synthetic Organic Chemistry
Early Disease Detection Performing NMR
Using Micro-CT Imaging for the Phenotyping and Analysis of Bone Architecture
Using High Fields to Combat Ischemic Stroke with Cell Therapy
Endodontic Applications of Microcomputed Tomography for Studying Root Canals
Studying Cardiovascular Pathology with MRI
Improved Open-Access NMR for the Synthetic and Analytical Chemistry Laboratories
DTI Connectomics in Mouse Models of Neurological Disorders
Monitoring Cancer Treatments with Immuno-PET
Early Detection of Metabolic Remodeling in Pressure Overload Left Ventricle Hypertrophy Using Dynamic PET Imaging
MicroCT Applications in Lung Research and Immunology
Micro-CT in 3D Data Integration and (Clinical) Workflows for Digital Orthodontics
Ex Vivo MicroangioCT: Advances in Microvascular Imaging
Treatments of COVID-19: Old Drugs, New Tricks
NMR Characterization of Polysaccharide-Based Vaccines
Hyperpolarized Xe MRI of Pulmonary Gas-Exchange in Rodents
PET Image Reconstruction Overview - Current and Future Trends
Unlocking your clinical understanding of Post-Acute COVID Syndrome (PACS), patient recover, and risk of subsequent disease
New Psychoactive Substances (NPS): automated identification and quantification
Present and future of human metabolomics (for research use only)
NMR based lipoprotein phenotyping can reveal recovery subgroups in SARS-CoV 2 infected patients
How to easily automate chemical mixture analysis
Evolving your biobank business model
Improving rapid narcotics analysis in the detection of illegal drugs
PET/MR imaging to study liver diseases